Exploring AI’s Role in Healthcare and Life Sciences

December 16

Insights from Prague Workshop

Artificial Intelligence (AI) is no longer a distant concept, it’s rapidly becoming integral to healthcare and life sciences. In the U.S., 85% of healthcare stakeholders are already exploring or adopting generative AI tools (McKinsey, 2025). In life sciences, the impact has been profound since the 2024 Nobel Prize in Chemistry recognized the creators of AlphaFold, a generative AI system that predicts protein structures, revolutionizing proteomics, molecular biology, and drug discovery.

A recent survey revealed that 96% of life sciences leaders believe AI tools will be essential within two years (ZDNET, 2025). Europe is part of this transformation, and our latest report captures regional advances presented at the “AI in Healthcare and Life Sciences” workshop, held in Prague on June 10, 2025, organized by AMIRES under the NAP4DIVE project.

Workshop Highlights

The event featured an opening keynote and three thematic sessions:

  1. AI in Life Sciences – From drug discovery to cell tracking
  2. AI-enabled Care – Applications in radiology and patient management
  3. Enabling AI Applications – Infrastructure, ethics, and legal implications

Discussions ranged from military applications to regulatory challenges, showcasing the breadth of AI’s impact.

Why This Matters

AI is accelerating innovation, improving efficiency, and opening new frontiers in healthcare and biomedical research. By fostering collaboration and knowledge exchange, events like this workshop help Europe stay competitive in this rapidly evolving landscape.

📥 Access the full report here: https://doi.org/10.5281/zenodo.17873049